Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials.
Win T, Lambrou T, Hutton BF, Kayani I, Screaton NJ, Porter JC, Maher TM, Endozo R, Shortman RI, Lukey P, Groves AM. Win T, et al. Among authors: porter jc. Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):521-8. doi: 10.1007/s00259-011-1986-7. Epub 2011 Nov 30. Eur J Nucl Med Mol Imaging. 2012. PMID: 22258710 Clinical Trial.
Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, Booth HL, Garrett E, Patel RS, Pavlou M, Groves AM, Elliott PM. Wicks EC, et al. Among authors: porter jc. Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):757-767. doi: 10.1093/ehjci/jex340. Eur Heart J Cardiovasc Imaging. 2018. PMID: 29319785
Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).
Win T, Screaton NJ, Porter JC, Ganeshan B, Maher TM, Fraioli F, Endozo R, Shortman RI, Hurrell L, Holman BF, Thielemans K, Rashidnasab A, Hutton BF, Lukey PT, Flynn A, Ell PJ, Groves AM. Win T, et al. Among authors: porter jc. Eur J Nucl Med Mol Imaging. 2018 May;45(5):806-815. doi: 10.1007/s00259-017-3917-8. Epub 2018 Jan 16. Eur J Nucl Med Mol Imaging. 2018. PMID: 29335764 Free PMC article. Clinical Trial.
Synergistic application of pulmonary 18F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF).
Fraioli F, Lyasheva M, Porter JC, Bomanji J, Shortman RI, Endozo R, Wan S, Bertoletti L, Machado M, Ganeshan B, Win T, Groves AM. Fraioli F, et al. Among authors: porter jc. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2023-2031. doi: 10.1007/s00259-019-04386-5. Epub 2019 Jul 8. Eur J Nucl Med Mol Imaging. 2019. PMID: 31286201 Free PMC article.
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study.
Porter JC, Win T, Erlandsson K, Fraioli F, Rashidnasab A, Holman B, Ganeshan B, Screaton NJ, Maher TM, Endozo R, Hoath J, Shortman RI, Emond E, Thielemans K, Hutton BF, Lukey PT, Aigbirhio F, Khan S, Rodriguez-Justo M, Groves AM. Porter JC, et al. Eur Respir J. 2021 Oct 7;58(4):2004584. doi: 10.1183/13993003.04584-2020. Print 2021 Oct. Eur Respir J. 2021. PMID: 34244317 Free article. No abstract available.
Evolution of 18F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation.
Thornton A, Fraioli F, Wan S, Garthwaite HS, Ganeshan B, Shortman RI, Endozo R, Vöö S, Kayani I, Neriman D, Menezes L, Bomanji J, Hilllman T, Heightman M, Porter JC, Groves AM. Thornton A, et al. Among authors: porter jc. J Nucl Med. 2022 Feb;63(2):270-273. doi: 10.2967/jnumed.121.262296. Epub 2021 Jul 16. J Nucl Med. 2022. PMID: 34272318 Free PMC article.
350 results